Data as of Nov 4, 2026.
GNMX vs GNOM: Holdings Overlap & Returns
GNMX and GNOM hold 44% of their weight in the same names.
askIQ about this page
askIQ about GNMX and GNOMNet assets: $1.3m on Nov 4, 2026 for Corgi Genomics & Precision Medicine ETF, and $104m on Oct 12, 2026 for Global X Genomics & Biotechnology ETF.
31% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.
21% of GNOM's weight is in S&P 500 companies and 79% is outside the index. Holdings as of Aug 31, 2026.
Pair scorecard
GNMX costs 0.15 points a year less; GNOM is far larger, $104m against $1.3m.
| Measure | GNMX | GNOM |
|---|---|---|
| Return | ||
| Total return, 1 year | not published | +66.6% |
| Drawdown | ||
| Below its all-time high | 36.2%, high on Feb 8, 2021 | |
| Benchmark | ||
| What it tracks | Genomics and gene editing | Genomics and gene editing |
| Cost and size | ||
| Expense ratio | 0.35% | 0.50% |
| Net assets, as of Oct 12, 2026 | $1.3m | $104m |
| Holdings | ||
| Holdings in common | 44% | |
What they share
By the books each fund has filed, GNMX and GNOM hold 44% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Nov 4, 2026.
half
44% in common
Only in one fund ↓
Window by window
| Total return | ||
|---|---|---|
| Window | GNMX | GNOM |
| 3 months | +24.3% | +24.5% |
| 6 months | +48.3% | +49.4% |
| 1 year | – | +66.6% |
| 3 years | – | +81.6% |
| Since launchNot the same days: GNMX May 2026 · GNOM Apr 2019 | +48.3% | +16.0% |
– means no data for this window. Open this comparison in the app →
Side by side
As of Nov 4, 2026. Source: ETFIQ.
44% of the two portfolios are the same securities at the same weight.
GNMX
By weight, 31% of GNMX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 49% of the fund across 57 positions, as published by its issuer for Nov 4, 2026. Since it first traded on May 6, 2026 the fund returned +48.3% with distributions reinvested.
GNOM
By weight, 21% of GNOM's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 49% of the fund across 50 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +66.6% with distributions reinvested. It sits 36.2% below its all-time high of Feb 8, 2021.
Questions people ask
- Do GNMX and GNOM hold the same stocks?
- By their latest filings, 44% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, GNMX against GNOM, data as of Nov 4, 2026. https://etfiq.com/compare/themes/gnmx-vs-gnom
ETFIQ. (Nov 4, 2026). GNMX against GNOM. Retrieved from https://etfiq.com/compare/themes/gnmx-vs-gnom
[GNMX against GNOM (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/themes/gnmx-vs-gnom)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.